AUPH
Aurinia Pharmaceuticals Inc.
NASDAQHealthcareBiotechnologyCA
Rating:A-
Company Profile
CEO
Kevin C. Tang
IPO Date
2014-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Aurinia Pharmaceuticals Inc.
CEO
Kevin C. Tang
IPO Date
2014-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
| 23,931 |
| $15.67 |
| 8 Jun 2026 | Nova Tina Susan | director | A-Award | Acquired | 23,931 | $15.67 |
| 8 Jun 2026 | Bailey Jeffrey Allen | director | A-Award | Acquired | 23,931 | $15.67 |
| 2 Jun 2026 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 2,299 | $15.35 |
| 2 Jun 2026 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 262,682 | $15.31 |
| 2 Jun 2026 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 343,521 | $15.28 |
| 2 Jun 2026 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 99 | $15.34 |
| 2 Jun 2026 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 206,005 | $15.28 |
| 2 Jun 2026 | TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | J-Other | Acquired | 10,000 | $15.00 |